You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

VINORELBINE TARTRATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Vinorelbine Tartrate patents expire, and when can generic versions of Vinorelbine Tartrate launch?

Vinorelbine Tartrate is a drug marketed by Actavis Totowa, Dr Reddys, Ebewe Pharma, Fresenius Kabi Usa, Hikma, Hospira, Jiangsu Hansoh Pharm, Mylan Labs Ltd, Novast Labs, and Teva Pharms Usa. and is included in eleven NDAs.

The generic ingredient in VINORELBINE TARTRATE is vinorelbine tartrate. There are fifteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the vinorelbine tartrate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Vinorelbine Tartrate

A generic version of VINORELBINE TARTRATE was approved as vinorelbine tartrate by HIKMA on June 10th, 2003.

  Try a Trial

Drug patent expirations by year for VINORELBINE TARTRATE
Recent Clinical Trials for VINORELBINE TARTRATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Phase 3
Qilu Pharmaceutical Co., Ltd.Phase 3
Zhiyong YuPhase 2

See all VINORELBINE TARTRATE clinical trials

Pharmacology for VINORELBINE TARTRATE
Drug ClassVinca Alkaloid

US Patents and Regulatory Information for VINORELBINE TARTRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Totowa VINORELBINE TARTRATE vinorelbine tartrate INJECTABLE;INJECTION 078011-001 Jul 22, 2009 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Hospira VINORELBINE TARTRATE vinorelbine tartrate INJECTABLE;INJECTION 076827-001 Jun 2, 2005 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Fresenius Kabi Usa VINORELBINE TARTRATE vinorelbine tartrate INJECTABLE;INJECTION 076849-001 Apr 18, 2005 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Jiangsu Hansoh Pharm VINORELBINE TARTRATE vinorelbine tartrate INJECTABLE;INJECTION 091106-001 Sep 26, 2012 AP RX No Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Dr Reddys VINORELBINE TARTRATE vinorelbine tartrate INJECTABLE;INJECTION 202017-001 Sep 12, 2013 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Ebewe Pharma VINORELBINE TARTRATE vinorelbine tartrate INJECTABLE;INJECTION 078408-001 Feb 13, 2008 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Hikma VINORELBINE TARTRATE vinorelbine tartrate INJECTABLE;INJECTION 076461-001 Dec 11, 2003 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.